Showing results (1011-1020 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|September 17, 2021
Porphyrin-Based Tumor-Targeting Theranostic Agent: Gd-TDAPSoyeon Kim, Ji-Ung Yang, Jae Hun Ahn, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin NeurohormoneJérémy Thireau, Justine Marteaux, Philippe Delagrange, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Ligand-Engineered Cu(II) Complexes Suppress Stemness and Drug Resistance in Triple-Negative Breast CancerVemavarapu Durga Prasad, Suriya Panneerselvam, Jyotirmoy Dutta, et al.ACS Medicinal Chemistry Letters|July 14, 2026
High-Throughput CETSA Identifies Small Molecule Modulators of ILT3 (LILRB4) with Functional Activity in Human iPSC-Derived Microglia for Alzheimer's DiseaseSomaya A Abdel-Rahman, Moustafa GabrACS Medicinal Chemistry Letters|July 14, 2026
Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer DrugKenichiro Shimokawa, Koji Ono, Moriteru Asano, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Novel Compounds as CDK4 Inhibitors for Treating Breast CancerRam W SabnisACS Medicinal Chemistry Letters|July 14, 2026
Novel Compounds as SARS-CoV‑2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus InfectionsRam W SabnisACS Medicinal Chemistry Letters|July 14, 2026
Novel Pyrrolidinone Derivatives as SARM1 Inhibitors for Treating Axonal DegenerationRam W Sabnis, Anika R SabnisACS Medicinal Chemistry Letters|July 14, 2026
Novel Substituted Carboxamides as SSTR4 AgonistsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|July 14, 2026
The Hyperpolarization-Activated, Cyclic-Nucleotide (HCN) Ion Channel Inhibitors as Potential Therapy for Pain, CNS Disorders, Psychiatric Disorders, and TinnitusAhmed F Abdel-MagidPageof 438